Systemic mastocytosis associated with acute myeloid leukaemia

Pathology. 2017 Oct;49(6):652-654. doi: 10.1016/j.pathol.2017.04.008. Epub 2017 Aug 18.

Authors

Min Jong Kim¹, Min Kyoung Kim², Yu Kyung Kim³, Mi Jin Gu⁴

Affiliations

¹ Department of Pathology, Yeungnam University College of Medicine, Daegu, Republic of Korea.
² Department of Hematology-Oncology, Yeungnam University College of Medicine, Daegu, Republic of Korea.
³ Department of Laboratory Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea.
⁴ Department of Pathology, Yeungnam University College of Medicine, Daegu, Republic of Korea. Electronic address: mjgu@yu.ac.kr.

PMID: 28826833
DOI: 10.1016/j.pathol.2017.04.008

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Biopsy, Needle
Bone Marrow / pathology
Cytarabine / therapeutic use
Humans
Idarubicin / therapeutic use
Immunohistochemistry
Induction Chemotherapy
Leukemia, Myeloid, Acute / complications
Leukemia, Myeloid, Acute / diagnosis*
Leukemia, Myeloid, Acute / genetics
Leukemia, Myeloid, Acute / pathology
Male
Mastocytosis, Systemic / complications
Mastocytosis, Systemic / diagnosis*
Mastocytosis, Systemic / genetics
Mastocytosis, Systemic / pathology
Proto-Oncogene Proteins c-kit / genetics*

Substances

Cytarabine
Proto-Oncogene Proteins c-kit
Idarubicin